Two generic drugmakers have agreed to the national settlement of a class action alleging that their version of a popular antidepressant drug was not as therapeutically effective as the brand-name drug.
February 06, 2012 at 12:00 AM
1 minute read
Two generic drugmakers have agreed to the national settlement of a class action alleging that their version of a popular antidepressant drug was not as therapeutically effective as the brand-name drug.
The drugmakers have agreed to give injunctive relief to the class by changing their product labels and taking other measures that the plaintiffs say will protect consumers.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
